Cargando…
Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436649/ https://www.ncbi.nlm.nih.gov/pubmed/37596585 http://dx.doi.org/10.1186/s13005-023-00386-x |
| _version_ | 1785092381813506048 |
|---|---|
| author | Brunner, Teresa F. Probst, Florian A. Troeltzsch, Matthias Schwenk‑Zieger, Sabina Zimmermann, Julia L. Morfill, Gregor Becker, Sven Harréus, Ulrich Welz, Christian |
| author_facet | Brunner, Teresa F. Probst, Florian A. Troeltzsch, Matthias Schwenk‑Zieger, Sabina Zimmermann, Julia L. Morfill, Gregor Becker, Sven Harréus, Ulrich Welz, Christian |
| author_sort | Brunner, Teresa F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10436649 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104366492023-08-19 Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study Brunner, Teresa F. Probst, Florian A. Troeltzsch, Matthias Schwenk‑Zieger, Sabina Zimmermann, Julia L. Morfill, Gregor Becker, Sven Harréus, Ulrich Welz, Christian Head Face Med Correction BioMed Central 2023-08-18 /pmc/articles/PMC10436649/ /pubmed/37596585 http://dx.doi.org/10.1186/s13005-023-00386-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Brunner, Teresa F. Probst, Florian A. Troeltzsch, Matthias Schwenk‑Zieger, Sabina Zimmermann, Julia L. Morfill, Gregor Becker, Sven Harréus, Ulrich Welz, Christian Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study |
| title | Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study |
| title_full | Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study |
| title_fullStr | Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study |
| title_full_unstemmed | Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study |
| title_short | Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study |
| title_sort | correction: primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for hnscc cells—an in‑vitro study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436649/ https://www.ncbi.nlm.nih.gov/pubmed/37596585 http://dx.doi.org/10.1186/s13005-023-00386-x |
| work_keys_str_mv | AT brunnerteresaf correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT probstfloriana correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT troeltzschmatthias correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT schwenkziegersabina correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT zimmermannjulial correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT morfillgregor correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT beckersven correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT harreusulrich correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy AT welzchristian correctionprimarycoldatmosphericplasmacombinedwithlowdosecisplatinasapossibleadjuvantcombinationtherapyforhnscccellsaninvitrostudy |